Try one of the below options to narrow down your search.
![]() |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2010 / 06 / 17
PHARMAC documents that matched your search:
Approval of proposal to list lopinavir 100 mg with ritonavir 25 mg.
(1 page, 139 KB)
2010/06/17
17 June 2010 Approval of proposal to list lopinavir 100 mg with ritonavir 25 mg PHARMAC is pleased to announce the approval of the proposal for the funding of lopinavir 100 mg in combination with ritonavir 25 mg tablets (Kaletra…
Atorvastatin – Sole Supply and Removal of the Special Authority
(3 pages, 148 KB)
2010/06/17
17 June 2010 Atorvastatin – Sole Supply and Removal of the Special Authority PHARMAC is pleased to announce that the approval of an agreement with Mylan New Zealand Ltd for Sole Supply Status of atorvastatin tablets (Lorstat). This was the…
Proposal to amend the Special Authority for cabergoline. Closed
(2 pages, 109 KB)
2010/06/17
17 June 2010 Proposal to amend the Special Authority for cabergoline PHARMAC is seeking feedback on a proposal to amend the Special Authority relating to funded cabergoline. In summary, this proposal would result in the Special Authority applying to cabergoline…
Proposal to fund a new brand of mycophenolate mofetil (Myaccord). Closed
(3 pages, 164 KB)
2010/06/17
17 June 2010 Proposal to fund a new brand of mycophenolate mofetil (Myaccord) and to widen funded access to that brand PHARMAC is seeking feedback on a proposal to fund Douglas Pharmaceutical’s brand of mycophenolate mofetil 250 mg capsule and…
Schedule Update - effective 1 July 2010
(69 pages, 797 KB)
2010/06/17
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2010 Cumulative for May, June and July 2010 Section H for April, May, June and July 2010 Contents Summary of PHARMAC decisions effective 1 July 2010 … 3 Topical…



